HK2 and hydrops fetalis: The inhibition of histone lactylation through HSC-specific or systemic deletion of hexokinase 2 effectively suppresses HSCs activation and hepatic fibrosis in vivo, highlighting a promising therapeutic target for the treatment of HF (Rho et al., 2023).